EUVIMEDEUVIMED entdecken
Crossref

KIRREL1 is a novel prognostic biomarker that promotes malignancy in gastric cancer via activation of the epithelial-mesenchymal transition pathway

Huohua Lv, Jun Liu, Lufei Jiang, ZhiWen Nie, Yaoxin Wang

Molecular Genetics and Genomics · 2026-12 · 301 (1)

DOI: 10.1007/s00438-026-02438-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics and Genomics, online erschienen am 19.05.2026. Verfasst von Huohua Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Wusong Central Hospital, Baoshan District, Shanghai, 200940, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Stomach Neoplasms, Biomarkers, Tumor, Membrane Proteins. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Baoshan District Health Commission Key Subject Construction Project, Shanghai Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionStomach NeoplasmsBiomarkers, TumorMembrane ProteinsHumansPrognosisCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationCell MovementFemaleFluorouracilMaleDrug Resistance, Neoplasm

Stichwörter der Autor:innen

ChemoresistanceEpithelial-mesenchymal transition (EMT)Gastric cancerKIRREL1MetastasisPrognosis

Substanzen

Biomarkers, TumorFluorouracilMembrane Proteins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Wusong Central Hospital, Baoshan District, Shanghai, 200940, China.
  • Department of Laboratory Medicine, Pudong New Area People's Hospital, Shanghai, China. zapjlf@163.com.
  • Department of Clinical Laboratory, Wusong Central Hospital, Baoshan District, Shanghai, 200940, China. niezhiwen@ws-hospital.sh.cn.
  • Department of Clinical Laboratory, Wusong Central Hospital, Baoshan District, Shanghai, 200940, China. wangyaoxin@ws-hospital.sh.cn.

Förderung

  • National Natural Science Foundation of China
  • Baoshan District Health Commission Key Subject Construction Project
  • Shanghai Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines

Zitieren

APA

Lv, H., Liu, J., Jiang, L., Nie, Z., & Wang, Y. (2026). KIRREL1 is a novel prognostic biomarker that promotes malignancy in gastric cancer via activation of the epithelial-mesenchymal transition pathway. Molecular Genetics and Genomics, 301(1). https://doi.org/10.1007/s00438-026-02438-8

Vancouver

Lv H, Liu J, Jiang L, Nie Z, Wang Y. KIRREL1 is a novel prognostic biomarker that promotes malignancy in gastric cancer via activation of the epithelial-mesenchymal transition pathway. Molecular Genetics and Genomics. 2026;301(1). doi:10.1007/s00438-026-02438-8

BibTeX
@article{Lv2026,
  author = {Lv, Huohua and Liu, Jun and Jiang, Lufei and Nie, ZhiWen and Wang, Yaoxin},
  title = {KIRREL1 is a novel prognostic biomarker that promotes malignancy in gastric cancer via activation of the epithelial-mesenchymal transition pathway},
  journal = {Molecular Genetics and Genomics},
  year = {2026},
  volume = {301},
  number = {1},
  doi = {10.1007/s00438-026-02438-8}
}
Kostenlos starten →